Featured Story Conformal Medical Raises $35 Million in Oversubscribed Series D Round June 6, 2023-Conformal
Sera Prognostics Announces Retirement of President and CEO Dr. Greg Critchfield and Appointment of Board Member Zhenya Lindgardt as Interim CEO May 15, 2023-Sera Prognostics
PanTher Therapeutics Awarded $14.2M from CPRIT to Advance Targeted, Localized and Sustained Cancer Treatment September 1, 2022-PanTher Therapeutics
Instylla announces positive results from preclinical studies of Embrace™ Hydrogel Embolic System in hemorrhage models August 1, 2022-Instylla Inc.
PanTher Therapeutics Secures Patent for Anticancer Drug-Eluting Stent May 31, 2022-PanTher Therapeutics
Sera Prognostics Presents Data Demonstrating the Health & Economic Benefit of PRETRM® Testing at Ispor Annual Meeting May 20, 2022-Sera Prognostics
Sera Prognostics and Newborn Foundation Partner to Reduce Risks Associated with Preterm Birth and Improve Health Equity Through the “Every Mother, Every Baby” Project May 5, 2022-Sera Prognostics
